Concepedia

Badiaa Bouzya

BB

Statistics

Publications

5

Citations

118

H-Index

5

Active since

2019

Affiliations

GlaxoSmithKline (Belgium)(Current)

GlaxoSmithKline (United States)

GlaxoSmithKline (Switzerland)

Badiaa Bouzya is an author at GlaxoSmithKline (Belgium) specializing in infectious diseases, vaccinology, and viral vaccines.

ORCID

Publications per year

2019–2023

5

Publications

5

Chimeric Hemagglutinin-Based Influenza Virus Vaccines Induce Protective Stalk-Specific Humoral Immunity and Cellular Responses in Mice

Angela Choi, Badiaa Bouzya, Klaus-Daniel Cortés Franco et al. · ImmunoHorizons · 2019 · 47 citations · Full text

, , +17

The RSVPreF3-AS01 vaccine elicits broad neutralization of contemporary and antigenically distant respiratory syncytial virus strains

Lionel Sacconnay, Jonathan De Smedt, Vera Rocha‐Perugini et al. · Science Translational Medicine · 2023 · 31 citations

, , +12

Immunogenicity of an AS01-adjuvanted respiratory syncytial virus prefusion F (RSVPreF3) vaccine in animal models

Badiaa Bouzya, Ronan Rouxel, Lionel Sacconnay et al. · npj Vaccines · 2023 · 17 citations · Full text

, , +17

Repeated Dose Toxicity Study and Developmental and Reproductive Toxicology Studies of a Respiratory Syncytial Virus Candidate Vaccine in Rabbits and Rats

Alan H. Stokes, Kelle Franklin, Daniel E. Fisher et al. · International Journal of Toxicology · 2021 · 12 citations

, , +17

ChAd155-RSV vaccine is immunogenic and efficacious against bovine RSV infection-induced disease in young calves

Rineke de Jong, Norbert Stockhofe-Zurwieden, Judith Bonsing et al. · Nature Communications · 2022 · 11 citations · Full text

, , +17

1–5 of 5